An Open Label Study of the Effect of Telaprevir in Combination With Ribavirin and Peginterferon on HCV Infection in Stable Liver Transplant Patients
Condition: Hepatitis CInterventions: Drug: Telaprevir; Drug: ribavirin; Drug: peginterferon alfa-2aSponsor: Vertex Pharmaceuticals IncorporatedCompleted - verified April 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 3, 2011 Category: Research Source Type: clinical trials
An Open Label Study of the Effect of Telaprevir in Combination With Ribavirin and Peginterferon on HCV Infection in Stable Liver Transplant Patients
Condition: Hepatitis CInterventions: Drug: Telaprevir; Drug: ribavirin; Drug: peginterferon alfa-2aSponsor: Vertex Pharmaceuticals IncorporatedActive, not recruiting - verified February 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 3, 2011 Category: Research Source Type: clinical trials
An Open Label Study of the Effect of Telaprevir in Combination With Ribavirin and Peginterferon on HCV Infection in Stable Liver Transplant Patients
Condition: Hepatitis CInterventions: Drug: Telaprevir; Drug: ribavirin; Drug: peginterferon alfa-2aSponsor: Vertex Pharmaceuticals IncorporatedCompleted - verified April 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 3, 2011 Category: Research Source Type: clinical trials
An Open Label Study of the Effect of Telaprevir in Combination With Ribavirin and Peginterferon on HCV Infection in Stable Liver Transplant Patients
Condition: Hepatitis CInterventions: Drug: Telaprevir; Drug: ribavirin; Drug: peginterferon alfa-2aSponsor: Vertex Pharmaceuticals IncorporatedActive, not recruiting - verified February 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 3, 2011 Category: Research Source Type: clinical trials